We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drafting Proposal to Extend Disqualifications Agencywide
FDA Drafting Proposal to Extend Disqualifications Agencywide
June 9, 2010
The FDA is drafting a proposed rule that would extend its authority so that clinical investigators disqualified for one type of trial, such as drugs, would be ineligible to conduct work on any other FDA-regulated investigational product, including biologics and devices.